Clinical trial
Safety and Short-term Oncological Outcomes of Thulium Fiber Laser En-bloc Resection of Non-muscle-invasive Bladder Cancer
NCT04110483 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Short-term Oncological Outcomes of Thulium Fiber Laser En-bloc Resection of Non-muscle-invasive Bladder Cancer
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- December 31, 2018
- Enrollment
- 130 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer